Factors associated with coverage of cotrimoxazole prophylaxis in HIV-exposed children in South Africa.
BACKGROUND: The World Health Organisation and the Joint United Nations Programme in 2006 reaffirmed the earlier recommendation of 2000 that all HIV-exposed infants in resource-poor countries should commence cotrimoxazole (CTX) prophylaxis at 6-weeks of life. CTX prophylaxis should be continued until...
Main Authors: | Dhayendre Moodley, Leanne Reddy, Wisani Mahungo, Rebotile Masha |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3646768?pdf=render |
Similar Items
-
Cotrimoxazole prophylaxis for adults with tuberculosis in rural South Africa
by: Grimwade, Katherine C.
Published: (2005) -
Eligibility for cotrimoxazole prophylaxis among adult HIVinfected patients in South Africa
by: S Takuva, et al.
Published: (2019-04-01) -
Cotrimoxazole prophylaxis and risk of severe anemia or severe neutropenia in HAART-exposed, HIV-uninfected infants.
by: Scott Dryden-Peterson, et al.
Published: (2013-01-01) -
Cotrimoxazole prophylaxis and tuberculosis risk among people living with HIV.
by: Christopher J Hoffmann, et al.
Published: (2014-01-01) -
Use of cotrimoxazole prophylactic treatment in HIV exposed children and its impact on malaria
by: Mbeye, Nyanyiwe
Published: (2014)